Mettler-Toledo/$MTD
1D1W1MYTD1Y5YMAX
Capital at risk
About Mettler-Toledo
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.
- Ticker
- $MTD
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 16,600
- Headquarters
- Greifensee, Switzerland
- Website
- www.mt.com
Mettler-Toledo Metrics
BasicAdvanced
$28B
31.33
$44.45
1.22
-
Price and volume
Market cap
$28B
Beta
1.22
52-week high
$1,525.17
52-week low
$1,023.05
Average daily volume
190K
Financial strength
Current ratio
1.122
Quick ratio
0.652
Long term debt to equity
159.503
Total debt to equity
166.684
Interest coverage (TTM)
17.21%
Profitability
EBITDA (TTM)
1,273.109
Gross margin (TTM)
60.26%
Net profit margin (TTM)
21.91%
Operating margin (TTM)
28.74%
Effective tax rate (TTM)
17.47%
Revenue per employee (TTM)
$250,000
Management effectiveness
Return on assets (TTM)
21.10%
Return on equity (TTM)
-736.36%
Valuation
Price to earnings (TTM)
31.327
Price to revenue (TTM)
6.845
Price to book
2,184.8
Price to tangible book (TTM)
-28.34
Price to free cash flow (TTM)
32.751
Free cash flow yield (TTM)
3.05%
Free cash flow per share (TTM)
42.512
Growth
Revenue change (TTM)
6.91%
Earnings per share change (TTM)
12.53%
3-year revenue growth (CAGR)
1.49%
10-year revenue growth (CAGR)
5.48%
3-year earnings per share growth (CAGR)
3.76%
10-year earnings per share growth (CAGR)
13.12%
What the Analysts think about Mettler-Toledo
Analyst ratings (Buy, Hold, Sell) for Mettler-Toledo stock.
Analyst projections of the future price of Mettler-Toledo stock.
Bulls say / Bears say
Mettler-Toledo beat expectations in Q2 2026 and raised full-year guidance to 4%–5% local-currency sales growth and $47.15–$47.50 adjusted EPS. Growth was broad, with particularly strong momentum in China and emerging markets. (Mettler-Toledo, The Motley Fool)
The company is gaining from attractive niches such as bioprocessing, automation, semiconductors and batteries, while new products and its LabX software are supporting laboratory demand. Service revenue grew 9% in Q2, or 7% organically, adding a more recurring and profitable element to the business. (The Motley Fool, Lab Manager)
Pricing, productivity and cost savings lifted Q2 adjusted operating margin to 29.3%, while management expects about $900 million of 2026 free cash flow. The planned $875 million share repurchase could further support per-share earnings if operating conditions remain stable. (Yahoo Finance, Watch List News)
Q2 reported profitability benefited from a one-off $52 million IEEPA tariff refund that reduced costs, partly offset by $28 million of tariff-related customer refunds. This makes the quarter’s margin and earnings strength less representative of the underlying run rate. (Mettler-Toledo, Watch List News)
The shares still command a premium valuation relative to conservative cash-flow estimates, leaving limited room for weaker growth or margins. Redburn’s recent Sell call specifically argued that the premium is difficult to justify against modest growth and tougher competition. (Simply Wall St, Simply Wall St)
Underlying demand remains uneven: Q2 reported sales fell 3% in the Americas, while full-year sales guidance is only 4%–5% and management warns that conditions can change quickly. The outlook also assumes no escalation of Middle East tensions, leaving room for delayed capital-equipment purchases if uncertainty increases. (Mettler-Toledo, The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 16 Sept 2026.
Mettler-Toledo Financial Performance
Revenues and expenses
Mettler-Toledo Earnings Performance
Company profitability
Upcoming events
No upcoming events
Mettler-Toledo News
AllArticlesVideos
Funds containing Mettler-Toledo
AllEURGBPUSD
Fund name | Fund size | $MTD weighting |
|---|---|---|
iShares MSCI World Health Care Sector Advanced€CBUF | €606M | 1.22% |
iShares S&P 500 Health Care Sector€IUHE | €125M | 0.46% |
iShares S&P 500 Equal Weight€O4J0 | €4.3B | 0.24% |
iShares S&P 500 Equal Weight£EWSP | £3.7B | 0.24% |
iShares MSCI USA SRI$SUAS | $3.4B | 0.20% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.